Fundraising Fox
Strategikon Pharma
San Francisco, US · Delaware corporation · 13 known investors
Find your way into Strategikon Pharma
Each arrow is one introduction. Sign up to fill in the first one.
Ask George McMillan to introduce you to Anca Copaescu
You →George · together at Pharmanet Development Group →Anca
Ask Jamie Chen to introduce you to Paulo Carvalho
You →Jamie · together at Strategikon Pharma →Paulo
Sign up to find every way you can get introduced to Strategikon Pharma
- Your email: who you already know at Strategikon Pharma, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Strategikon Pharma team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Strategikon Pharma develops Clinical Maestro, a software platform for managing clinical business operations including budgeting, sourcing, contracting, and vendor management, with AI-driven cost benchmarking tools. It serves biopharmaceutical companies of all sizes and Clinical Research Organizations (CROs) involved in clinical trial outsourcing.
Founders & leadership
Board
Investors · 13
How we know: av.vc · Not right? Tell us
How we know: prnewswire.com · Not right? Tell us
How we know: Debiopharm Innovation Fund's portfolio page · Not right? Tell us
How we know: prnewswire.com · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: a partner's Signal profile · prnewswire.com · the VCSheet dataset · Not right? Tell us
How we know: prnewswire.com · the VCSheet dataset · Not right? Tell us
How we know: prnewswire.com · Not right? Tell us
How we know: a partner's Signal profile · Not right? Tell us
Also in the syndicate · 3
Funding
SEC filings, press & company announcements$2.3M disclosed across 1 of 4 rounds · 2017–2025
- Undisclosed amountSeries AApr 2021
Osage Venture Partners (lead), Band of Angels, Bascom Ventures, Golden Seeds, Life Science Angels, Saratoga Ventures, Inc., Tech Coast Angels, Wing Venture Capital
Source ↗
▶$2.3MraisedNov 2025 · 15 investors · Other TechnologyRule 506(b)
- Rob HessDirector
- Anca CopaescuExecutive Officer, Director
- Debra ApruzzeseDirector
- Chris CodeanneDirector
- Paulo CarvalhoExecutive Officer
- Vincent LepreuxDirector
- Mark WeinsteinExecutive Officer, Director
- Nathanael LentzDirector
- Offering amount
- $3M
- Amount sold
- $2.3M
- First sale
- May 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶Undisclosed amountofferedApr 2018 · Business ServicesRule 506(b)
- Anca CopaescuExecutive Officer, Director, Promoter
- Paulo CarvalhoExecutive Officer, Promoter
- Mark Di IanniExecutive Officer, Director, Promoter
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 04, 06b
▶$1MofferedNov 2017 · Business ServicesRule 506(b)
- Mark Di IanniExecutive Officer, Director, Promoter
- Paulo CarvalhoExecutive Officer, Director, Promoter
- Anca CopaescuExecutive Officer, Director, Promoter
- Offering amount
- $1M
- Minimum investment
- $20K
- Proceeds to insiders
- $150K
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 04, 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Strategikon Pharma do?
- Strategikon Pharma develops Clinical Maestro, a software platform for managing clinical business operations including budgeting, sourcing, contracting, and vendor management, with AI-driven cost benchmarking tools. It serves biopharmaceutical companies of all sizes and Clinical Research Organizations (CROs) involved in clinical trial outsourcing.
- Who founded Strategikon Pharma?
- Strategikon Pharma was founded by Anca Copaescu, Mark Di Ianni.
- Who are Strategikon Pharma's investors?
- Strategikon Pharma's investors include Alumni Ventures, Band of Angels, Debiopharm Innovation Fund, HearstLab, Bascom Ventures, Decathlon Capital Partners, Golden Seeds, Osage Venture Partners and 2 more.
- How much funding has Strategikon Pharma raised?
- Strategikon Pharma has disclosed $2.3M raised across 1 of its 4 known rounds.
- Where is Strategikon Pharma headquartered?
- Strategikon Pharma is headquartered in San Francisco, US.